collect clinical data in Chinese patients received CUBICIN treatment for actual usage in clinical practice
Study identifier:NIS-ICN-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Multicenter, observational, non-interventional registry designed to collect clinical data in Chinese patients who have received CUBICIN® treatment under condition of actual usage in clinical practice
Medical condition
S. aureus bloodstream infection
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
203
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jan 2011
Primary Completion Date: 01 Nov 2012
Study Completion Date: 01 Nov 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 | - |
Contacts
Investigators
Principal Investigator
Aixia Wang
Peiking Union Medical College Hospital
